PubMed

Sitagliptin 100 mg daily effect on DPP-4 inhibition and compound-specific glycemic improvement.

Alba M, Sheng D, Guan Y, Williams-Herman D, Larson P, Sachs JR, Thornberry N, Herman G, Kaufman KD, Goldstein BJ.

Curr Med Res Opin. 2009 Oct;25(10):2507-14.PMID: 19691426 [PubMed - in process]Related articles

Inflammatory Signaling: Another Drug Target to Improve Glycemic Control in Type 2 Diabetes.

Goldstein BJ.

Clin Transl Sci. 2008 May 21;1(1):43-44. No abstract available. PMID: 19468293 [PubMed]Related articlesFree article

Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study.

Williams-Herman D, Johnson J, Teng R, Luo E, Davies MJ, Kaufman KD, Goldstein BJ, Amatruda JM.

Curr Med Res Opin. 2009 Mar;25(3):569-83.PMID: 19232032 [PubMed - in process]Related articles

AMP-activated protein kinase deficiency enhances myocardial ischemia/reperfusion injury but has minimal effect on the antioxidant/antinitrative protection of adiponectin.

Wang Y, Gao E, Tao L, Lau WB, Yuan Y, Goldstein BJ, Lopez BL, Christopher TA, Tian R, Koch W, Ma XL.

Circulation. 2009 Feb 17;119(6):835-44. Epub 2009 Feb 2.PMID: 19188503 [PubMed - indexed for MEDLINE]Related articles

Modern management of chylous leak following head and neck surgery: a discussion of percutaneous lymphangiography-guided cannulation and embolization of the thoracic duct.

Scorza LB, Goldstein BJ, Mahraj RP.

Otolaryngol Clin North Am. 2008 Dec;41(6):1231-40, xi. Review.PMID: 19040982 [PubMed - indexed for MEDLINE]Related articles

Coronary artery disease screening in patients with diabetes.

Savarese V, Ahmed I, Goldstein BJ.

Endocrine. 2008 Jun;33(3):225-9. Review.PMID: 19034704 [PubMed - indexed for MEDLINE]Related articles

Protective vascular and myocardial effects of adiponectin.

Goldstein BJ, Scalia RG, Ma XL.

Nat Clin Pract Cardiovasc Med. 2009 Jan;6(1):27-35. Epub 2008 Nov 25. Review.PMID: 19029992 [PubMed - indexed for MEDLINE]Related articlesFree article

The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program.

Moore AF, Jablonski KA, Mason CC, McAteer JB, Arakaki RF, Goldstein BJ, Kahn SE, Kitabchi AE, Hanson RL, Knowler WC, Florez JC; Diabetes Prevention Program Research Group.

J Clin Endocrinol Metab. 2009 Feb;94(2):449-55. Epub 2008 Nov 18.PMID: 19017751 [PubMed - indexed for MEDLINE]Related articles

Rottlerin activates AMPK possibly through LKB1 in vascular cells and tissues.

Kojima K, Motoshima H, Tsutsumi A, Igata M, Matsumura T, Kondo T, Kawashima J, Ichinose K, Furukawa N, Inukai K, Katayama S, Goldstein BJ, Nishikawa T, Tsuruzoe K, Araki E.

Biochem Biophys Res Commun. 2008 Nov 14;376(2):434-8. Epub 2008 Sep 19.PMID: 18789895 [PubMed - indexed for MEDLINE]Related articles

Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes.

Jabbour SA, Goldstein BJ.

Int J Clin Pract. 2008 Aug;62(8):1279-84. Review.PMID: 18705823 [PubMed - indexed for MEDLINE]Related articles

Type 2 diabetes: pathogenesis and treatment.

Stumvoll M, Goldstein BJ, van Haeften TW.

Lancet. 2008 Jun 28;371(9631):2153-6. No abstract available. PMID: 18586159 [PubMed - indexed for MEDLINE]Related articles

Modulating an oxidative-inflammatory cascade: potential new treatment strategy for improving glucose metabolism, insulin resistance, and vascular function.

Lamb RE, Goldstein BJ.

Int J Clin Pract. 2008 Jul;62(7):1087-95. Epub 2008 May 16. Review.PMID: 18489578 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells.

Nakamura Y, Patrushev N, Inomata H, Mehta D, Urao N, Kim HW, Razvi M, Kini V, Mahadev K, Goldstein BJ, McKinney R, Fukai T, Ushio-Fukai M.

Circ Res. 2008 May 23;102(10):1182-91. Epub 2008 May 1.PMID: 18451337 [PubMed - indexed for MEDLINE]Related articlesFree article

Adiponectin regulates albuminuria and podocyte function in mice.

Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, Falkner B, Goldstein BJ.

J Clin Invest. 2008 May;118(5):1645-56.PMID: 18431508 [PubMed - indexed for MEDLINE]Related articlesFree article

An atypical case of fatal zygomycosis: simultaneous cutaneous and laryngeal infection in a patient with a non-neutropenic solid prostatic tumor.

Johnson KE, Leahy K, Owens C, Blankson JN, Merz WG, Goldstein BJ.

Ear Nose Throat J. 2008 Mar;87(3):152-5. Review.PMID: 18404912 [PubMed - indexed for MEDLINE]Related articles

Adiponectin protects against angiotensin II or tumor necrosis factor alpha-induced endothelial cell monolayer hyperpermeability: role of cAMP/PKA signaling.

Xu SQ, Mahadev K, Wu X, Fuchsel L, Donnelly S, Scalia RG, Goldstein BJ.

Arterioscler Thromb Vasc Biol. 2008 May;28(5):899-905. Epub 2008 Feb 21.PMID: 18292388 [PubMed - indexed for MEDLINE]Related articlesFree article

Pathogenesis of type 2 diabetes.

Stumvoll M, Goldstein BJ, van Haeften TW.

Endocr Res. 2007;32(1-2):19-37. Review. No abstract available. PMID: 18271503 [PubMed - indexed for MEDLINE]Related articles

Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells.

Mahadev K, Wu X, Donnelly S, Ouedraogo R, Eckhart AD, Goldstein BJ.

Cardiovasc Res. 2008 May 1;78(2):376-84. Epub 2008 Feb 10.PMID: 18267956 [PubMed - indexed for MEDLINE]Related articlesFree article

Type 2 diabetes--treat early, treat intensively.

Goldstein BJ, Gomis R, Lee HK, Leiter LA; Global Partnership for Effective Diabetes Management.

Int J Clin Pract Suppl. 2007 Dec;(157):16-21. Review.PMID: 17991187 [PubMed - indexed for MEDLINE]Related articles

Adiponectin suppresses IkappaB kinase activation induced by tumor necrosis factor-alpha or high glucose in endothelial cells: role of cAMP and AMP kinase signaling.

Wu X, Mahadev K, Fuchsel L, Ouedraogo R, Xu SQ, Goldstein BJ.

Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1836-44. Epub 2007 Oct 16.PMID: 17940218 [PubMed - indexed for MEDLINE]Related articlesFree article

Mindfulness-based stress reduction is associated with improved glycemic control in type 2 diabetes mellitus: a pilot study.

Rosenzweig S, Reibel DK, Greeson JM, Edman JS, Jasser SA, McMearty KD, Goldstein BJ.

Altern Ther Health Med. 2007 Sep-Oct;13(5):36-8.PMID: 17900040 [PubMed - indexed for MEDLINE]Related articles

Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity.

Li R, Wang WQ, Zhang H, Yang X, Fan Q, Christopher TA, Lopez BL, Tao L, Goldstein BJ, Gao F, Ma XL.

Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1703-8. Epub 2007 Sep 25.PMID: 17895290 [PubMed - indexed for MEDLINE]Related articlesFree article

Important role of Nox4 type NADPH oxidase in angiogenic responses in human microvascular endothelial cells in vitro.

Datla SR, Peshavariya H, Dusting GJ, Mahadev K, Goldstein BJ, Jiang F.

Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2319-24. Epub 2007 Aug 23.PMID: 17717289 [PubMed - indexed for MEDLINE]Related articlesFree article

Initial treatment with fixed-dose combination rosiglitazone/glimepiride in patients with previously untreated type 2 diabetes.

Chou HS, Palmer JP, Jones AR, Waterhouse B, Ferreira-Cornwell C, Krebs J, Goldstein BJ.

Diabetes Obes Metab. 2008 Aug;10(8):626-37. Epub 2007 Jul 21.PMID: 17645558 [PubMed - indexed for MEDLINE]Related articles

Comment on: Hattori et al. (2007) Globular adiponectin activates nuclear factor-kappaB and activating protein-1 and enhances angiotensin II-induced proliferation in cardiac fibroblasts: Diabetes 56:804-808.

Goldstein BJ, Scalia R, Ma XL, Mahadev K, Wu X, Ouedraogo R.

Diabetes. 2007 Jul;56(7):e7-8; author reply e9-10. No abstract available. PMID: 17596407 [PubMed - indexed for MEDLINE]Related articlesFree article

Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo.

Ouedraogo R, Gong Y, Berzins B, Wu X, Mahadev K, Hough K, Chan L, Goldstein BJ, Scalia R.

J Clin Invest. 2007 Jun;117(6):1718-26.PMID: 17549259 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes.

Goldstein BJ, Feinglos MN, Lunceford JK, Johnson J, Williams-Herman DE; Sitagliptin 036 Study Group.

Diabetes Care. 2007 Aug;30(8):1979-87. Epub 2007 May 7. Erratum in: Diabetes Care. 2008 Aug;31(8):1713. PMID: 17485570 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical translation of "a diabetes outcome progression trial": ADOPT appropriate combination oral therapies in type 2 diabetes.

Goldstein BJ.

J Clin Endocrinol Metab. 2007 Apr;92(4):1226-8. No abstract available. PMID: 17409340 [PubMed - indexed for MEDLINE]Related articlesFree article

Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress.

Tao L, Gao E, Jiao X, Yuan Y, Li S, Christopher TA, Lopez BL, Koch W, Chan L, Goldstein BJ, Ma XL.

Circulation. 2007 Mar 20;115(11):1408-16. Epub 2007 Mar 5.PMID: 17339545 [PubMed - indexed for MEDLINE]Related articlesFree article

Dual PPAR alpha/gamma agonists: promises and pitfalls in type 2 diabetes.

Ahmed I, Furlong K, Flood J, Treat VP, Goldstein BJ.

Am J Ther. 2007 Jan-Feb;14(1):49-62. Review.PMID: 17303976 [PubMed - indexed for MEDLINE]Related articles

Adipokines and vascular disease in diabetes.

Goldstein BJ, Scalia R.

Curr Diab Rep. 2007 Feb;7(1):25-33. Review.PMID: 17254515 [PubMed - indexed for MEDLINE]Related articles

Effect of tesaglitazar, a dual PPAR alpha/gamma agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12-week dose-ranging trial.

Goldstein BJ, Rosenstock J, Anzalone D, Tou C, Ohman KP.

Curr Med Res Opin. 2006 Dec;22(12):2575-90.PMID: 17166340 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular risk in the spectrum of type 2 diabetes mellitus.

Ahmed I, Goldstein BJ.

Mt Sinai J Med. 2006 Sep;73(5):759-68. Review.PMID: 17008936 [PubMed - indexed for MEDLINE]Related articlesFree article

Reductions in biomarkers of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study.

Goldstein BJ, Weissman PN, Wooddell MJ, Waterhouse BR, Cobitz AR.

Curr Med Res Opin. 2006 Sep;22(9):1715-23.PMID: 16968575 [PubMed - indexed for MEDLINE]Related articles

Concurrent sporadic parathyroid adenoma and carcinoma.

Pai SI, Goldstein BJ, Studeman KD, Westra WH, Tufano RP.

Am J Otolaryngol. 2006 Sep-Oct;27(5):346-8. No abstract available. PMID: 16935182 [PubMed - indexed for MEDLINE]Related articles

Intensive insulin therapy regimens: is there a difference in patient satisfaction?

Goldstein BJ.

Nat Clin Pract Endocrinol Metab. 2005 Dec;1(2):80-1. No abstract available. PMID: 16929375 [PubMed]Related articles

TLR4-NOX4-AP-1 signaling mediates lipopolysaccharide-induced CXCR6 expression in human aortic smooth muscle cells.

Patel DN, Bailey SR, Gresham JK, Schuchman DB, Shelhamer JH, Goldstein BJ, Foxwell BM, Stemerman MB, Maranchie JK, Valente AJ, Mummidi S, Chandrasekar B.

Biochem Biophys Res Commun. 2006 Sep 8;347(4):1113-20. Epub 2006 Jul 13.PMID: 16870145 [PubMed - indexed for MEDLINE]Related articles

Closing the gap between clinical research and clinical practice: can outcome studies with thiazolidinediones improve our understanding of type 2 diabetes?

Goldstein BJ.

Int J Clin Pract. 2006 Jul;60(7):873-83. Review.PMID: 16846404 [PubMed - indexed for MEDLINE]Related articles

Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway.

Ouedraogo R, Wu X, Xu SQ, Fuchsel L, Motoshima H, Mahadev K, Hough K, Scalia R, Goldstein BJ.

Diabetes. 2006 Jun;55(6):1840-6.PMID: 16731851 [PubMed - indexed for MEDLINE]Related articlesFree article

AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer.

Motoshima H, Goldstein BJ, Igata M, Araki E.

J Physiol. 2006 Jul 1;574(Pt 1):63-71. Epub 2006 Apr 13. Review.PMID: 16613876 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE Study.

Weissman P, Goldstein BJ, Rosenstock J, Waterhouse B, Cobitz AR, Wooddell MJ, Strow LJ.

Curr Med Res Opin. 2005 Dec;21(12):2029-35.PMID: 16368054 [PubMed - indexed for MEDLINE]Related articles

Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study.

Rosenstock J, Goldstein BJ, Vinik AI, O'neill MC, Porter LE, Heise MA, Kravitz B, Dirani RG, Freed MI; RESULT Study Group.

Diabetes Obes Metab. 2006 Jan;8(1):49-57.PMID: 16367882 [PubMed - indexed for MEDLINE]Related articles

Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.

Rosenberg DE, Jabbour SA, Goldstein BJ.

Diabetes Obes Metab. 2005 Nov;7(6):642-53. Review.PMID: 16219008 [PubMed - indexed for MEDLINE]Related articles

Reactive oxygen species production via NADPH oxidase mediates TGF-beta-induced cytoskeletal alterations in endothelial cells.

Hu T, Ramachandrarao SP, Siva S, Valancius C, Zhu Y, Mahadev K, Toh I, Goldstein BJ, Woolkalis M, Sharma K.

Am J Physiol Renal Physiol. 2005 Oct;289(4):F816-25.PMID: 16159901 [PubMed - indexed for MEDLINE]Related articlesFree article

Endoscopic repair of a hypopharyngeal laceration in a professional sword-swallower.

Goldstein BJ, Yang SC, Brockenbrough JM.

Otolaryngol Head Neck Surg. 2005 Aug;133(2):302-4. No abstract available. PMID: 16087033 [PubMed - indexed for MEDLINE]Related articles

Role of insulin-induced reactive oxygen species in the insulin signaling pathway.

Goldstein BJ, Mahadev K, Wu X, Zhu L, Motoshima H.

Antioxid Redox Signal. 2005 Jul-Aug;7(7-8):1021-31. Review.PMID: 15998257 [PubMed - indexed for MEDLINE]Related articlesFree article

Hyperglycemia potentiates H(2)O(2) production in adipocytes and enhances insulin signal transduction: potential role for oxidative inhibition of thiol-sensitive protein-tyrosine phosphatases.

Wu X, Zhu L, Zilbering A, Mahadev K, Motoshima H, Yao J, Goldstein BJ.

Antioxid Redox Signal. 2005 May-Jun;7(5-6):526-37.PMID: 15889998 [PubMed - indexed for MEDLINE]Related articlesFree article

Type 2 diabetes: principles of pathogenesis and therapy.

Stumvoll M, Goldstein BJ, van Haeften TW.

Lancet. 2005 Apr 9-15;365(9467):1333-46. Review.PMID: 15823385 [PubMed - indexed for MEDLINE]Related articles

Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets.

Goldstein BJ, Mahadev K, Wu X.

Diabetes. 2005 Feb;54(2):311-21. Review. Erratum in: Diabetes. 2005 Apr;54(4):1249. Kalyankar, Mahadev [corrected to Mahadev, Kalyankar]. PMID: 15677487 [PubMed - indexed for MEDLINE]Related articlesFree article

Future directions in chemosensory research.

Goldstein BJ, Lane AP.

Otolaryngol Clin North Am. 2004 Dec;37(6):1281-93. Review.PMID: 15563914 [PubMed - indexed for MEDLINE]Related articles